Aptamer therapeutics useful in the treatment of complement-related disorders
US7538211B2 · kind B2 · utility
18Cited by
36References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 2005 |
| Grant date | May 26, 2009 |
| Priority date | — |
| Expiry date | Dec 22, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.